DDRE-23. THE COMBINATION PARP INHIBITOR OLAPARIB WITH TEMOZOLOMIDE IN AN EXPERIMENTAL GLIOBLASTOMA MODEL

Poly (ADP-ribose) polymerase (PARP) inhibition could enhance the efficacy of temozolomide and prolong survival in patients with glioblastoma. The aim of this study was to evaluate the combination of the PARP inhibitor olaparib with temozolomide in the treatment of glioblastoma by evaluating in vitro...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Neuro Oncol
Main Authors: Hwang, Kihwan, Go, Kyeong-O, Kim, Sang Ho, Lee, Hyunwoo, Han, Jung Ho, Kim, Chae-Yong
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2020
Fag:
Drug Discovery, Drug Resistance
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651703/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.268
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker